You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: February 14, 2025

Drug Price Trends for INF ACETAMINOPHEN


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for INF ACETAMINOPHEN

Average Pharmacy Cost for INF ACETAMINOPHEN

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
INF ACETAMINOPHEN 160 MG/5 ML 00536-1212-77 0.05492 ML 2025-01-22
INF ACETAMINOPHEN 160 MG/5 ML 00536-1426-77 0.05492 ML 2025-01-22
INF ACETAMINOPHEN 160 MG/5 ML 00536-1426-77 0.05477 ML 2024-12-18
INF ACETAMINOPHEN 160 MG/5 ML 00536-1212-77 0.05477 ML 2024-12-18
INF ACETAMINOPHEN 160 MG/5 ML 00536-1426-77 0.05492 ML 2024-11-27
INF ACETAMINOPHEN 160 MG/5 ML 00536-1212-77 0.05492 ML 2024-11-20
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Acetaminophen Market Analysis and Price Projections

Market Overview

The global acetaminophen market is poised for significant growth, driven by several key factors. As of 2024, the market was valued at USD 10.83 billion and is projected to reach USD 19.19 billion by 2037, growing at a CAGR of more than 4.5% during the forecast period of 2025-2037[1].

Growth Drivers

  1. Increasing Global Population and Health Issues: The global population is growing at a rate of nearly 1% annually, leading to an increased demand for healthcare services and medications like acetaminophen. This growth is particularly pronounced in the Asia-Pacific region, where government campaigns to enhance health awareness and accessibility of quality healthcare are driving the market[1].

  2. Chronic Illnesses and Pain Management: The rise in chronic illnesses such as cancer, chronic obstructive pulmonary disease (COPD), and other conditions requiring ongoing pain relief is a major driver. Acetaminophen is widely used for managing mild to moderate pain, making it a staple in many households and medical facilities[3].

  3. Opioid Tolerance and Overuse: The increasing concern over opioid tolerance and addiction has led to a shift towards non-opioid pain relievers like acetaminophen. This trend is expected to continue, providing a significant growth opportunity for the acetaminophen market[3].

Market Segmentation

  1. Route of Administration: The oral route of administration dominates the market, accounting for approximately 92.4% of the total market share in recent years. This is due to the convenience and efficacy of oral formulations[3][4].

  2. Sales Type: Over-the-counter (OTC) sales account for a significant portion of the market, with around 91.6% of the global market share in 2021. Retail pharmacies are also a major distribution channel, holding about 28.5% of the total market share[4].

  3. Geographical Distribution:

    • Asia-Pacific: This region is expected to dominate the market, with India and China being major producers and consumers. The region is projected to hold over 32% of the revenue share by 2037[1].
    • North America: Currently holds the largest share of the global acetaminophen market, with a significant presence of key market players[4].

Price Trends and Projections

  1. Current Price Trends:

    • In the second quarter of 2024, the acetaminophen market in North America and Europe experienced a decline in prices due to global oversupply and reduced demand from international buyers. This trend was also influenced by easing geopolitical tensions and reduced shipping costs[2].
    • In Asia, particularly in India, the prices fluctuated due to changes in raw material costs and government interventions. For instance, the National Pharmaceutical Pricing Authority (NPPA) announced a minor increase in the Maximum Retail Price of essential medicines, including acetaminophen, effective from April 1, 2024[2].
  2. Future Price Projections:

    • The price trend of acetaminophen is expected to follow a weak trend in the short term due to slow arrival of downstream orders and challenging global trading dynamics. However, in the long term, prices are anticipated to rise due to increasing demand and production costs driven by inflation and rising feedstock chemical costs[2].
    • In Asian countries, the price trend is expected to surge in the forthcoming quarters, driven by increased demand and government regulations[2].

Challenges and Opportunities

  1. Competition and Generics: The acetaminophen market faces intense competition from generic manufacturers, which can impact market growth. However, this also presents opportunities for innovative and cost-effective solutions[5].

  2. Technological Advancements: Modernization in paracetamol production and rising research and development activities in the healthcare sector are expected to create new opportunities for the acetaminophen market[5].

  3. Sustainability and Regulatory Environment: The growing focus on sustainable chemistry and regulatory changes can pose challenges but also offer opportunities for market players to adapt and innovate[5].

Key Players and Market Structure

The acetaminophen market is dominated by several key players, including Pfizer Inc., Sanofi, Janssen Pharmaceuticals, Bayer AG, GlaxoSmithKline plc, and others. These companies are involved in various strategies such as product innovation, expansion into emerging markets, and strategic partnerships to maintain their market share[3].

Regional Outlook

  1. Asia-Pacific:

    • This region is expected to dominate the market due to the rapid economic growth in countries like India and China. Government initiatives to improve healthcare access and increasing health awareness are driving the demand for acetaminophen[1][3].
  2. North America and Europe:

    • These regions hold significant market shares due to the high prevalence of chronic diseases and the widespread use of acetaminophen for pain management. However, they are also experiencing challenges such as oversupply and reduced demand[2][4].

Key Takeaways

  • The global acetaminophen market is projected to grow significantly, driven by increasing global population, chronic illnesses, and the need for non-opioid pain relievers.
  • The Asia-Pacific region is expected to dominate the market due to its large population and growing healthcare needs.
  • Price trends are expected to be influenced by global supply and demand dynamics, as well as regulatory changes.
  • Key players are focusing on innovation, expansion, and strategic partnerships to maintain their market share.

FAQs

Q: What is the current market size of the global acetaminophen market?

  • The global acetaminophen market was valued at USD 10.83 billion in 2024[1].

Q: What is the projected growth rate of the acetaminophen market?

  • The market is expected to grow at a CAGR of more than 4.5% from 2025 to 2037[1].

Q: Which region is expected to dominate the acetaminophen market?

  • The Asia-Pacific region is expected to dominate the market, holding over 32% of the revenue share by 2037[1].

Q: What are the main drivers of the acetaminophen market?

  • The main drivers include the increasing global population, rise in chronic illnesses, and the need for non-opioid pain relievers[1][3].

Q: How is the price trend of acetaminophen expected to change in the future?

  • The price trend is expected to follow a weak trend in the short term but is anticipated to rise in the long term due to increasing demand and production costs[2].

Cited Sources

  1. Research Nester: Acetaminophen Market Size & Share, Growth Trends 2037
  2. Procurement Resource: Acetaminophen Price Trend and Forecast
  3. Future Market Insights: Acetaminophen Market Size, Share, Trends & Outlook - 2033
  4. GlobeNewswire: Acetaminophen Market to be worth US$ 14.07 Billion by the year 2031
  5. Value Market Research: Global Acetaminophen Market Research Report - Industry Analysis

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.